Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Susac’s Syndrome: Confusion, Expressive Aphasia, Gait Instability

Candace H. Feldman, MD, MPH, Gwendolyn Kane-Wagner, MD  |  Issue: March 2012  |  March 8, 2012

In a clinical pathologic conference presented in the New England Journal of Medicine (NEJM) in 2011, a brain biopsy in a patient with Susac’s syndrome was performed. Findings demonstrated swollen endothelial cells, a small amount of mononuclear-cell perivascular inflammation, and intraluminal hyaline thrombi, suggestive of a microangiopathy.11 There was no evidence of granulomatous angiitis, demyelination, malignancy, or infection. In other cases, brain biopsy has revealed both acute and subacute microinfarcts, and changes in the microvasculature, similar to the NEJM case.11-14

MRI findings in Susac’s syndrome include small, multifocal T2 hyperintensities, most notably in the cerebral white matter and the corpus callosum, and approximately 30% have leptomeningeal enhancement.15 Lesions are hyperintense on FLAIR images. All of the reported cases involve the corpus callosum, usually the central fibers, but spare the periphery, which is distinct from the MRI findings in patients with MS or ADEM.6 This feature was also seen in our patient. Given the small size of the vessels involved, MRA and standard cerebral angiography are normal in patients with Susac’s syndrome. EEG findings are nonspecific.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Figure 2: Fluorescein angiography reveals cotton wool spots (blue arrows), box-carring (yellow arrows), and peripheral retinal arteriolar branch occlusions (green arrows) in the right eye (A-C) and a focally inflamed retinal arteriole (red arrows) in the left eye (D).

Fluorescein angiography of the retina often shows hyperfluorescence of the wall of the retinal arterioles, and complete occlusion of distal branches.16 The occlusions may be associated with Gass plaques, atheromatous deposits caused by leakage of lipids into the arterial wall at the site of damage.16 Cotton wool patches and boxcar segmentation may also be seen, as was seen in our patient. Pathologic analysis of the retina have demonstrated serous deposits, with compression of retinal vessel lumens, no thrombosis, and decreased adenosine diphosphatase (ADPase) activity suggesting endothelial cell dysfunction and vaso-occlusion.17 Patients do not have visual loss when the occlusions spare the macula.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Susac’s syndrome also includes sensorineural hearing loss, usually of low to mid-frequency, which can be insidious in onset, and either unilateral or bilateral.18 It is sometimes associated with ataxia, vertigo, and nausea, consistent with symptoms experienced by our patient. SG is currently awaiting audiologic evaluation to confirm physical examination findings of right-sided hearing loss.

The clinical course of Susac’s syndrome tends to be self-limited, but can recur, and varies in duration from six months to five years.16 Approximately 60% to 70% of patients experience some degree of persistent encephalopathy, which may manifest as psychiatric disturbances or dementia.6,9,16 The prognosis for recovery of hearing is variable, with some persistence of hearing loss but with improvement in tinnitus and vertigo.19 Visual loss recovery depends on the areas of the retina involved.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Career DevelopmentConditionsEducation & TrainingOther Rheumatic ConditionsProfessional Topics Tagged with:ANA titerDiagnostic Criteriadrugimagingintravenous immunoglobulinsPathogenesispatient careprednisonerheumatologistTreatment

Related Articles

    Watch Those Eyes

    December 1, 2007

    What you need to know about Uveitis in Rheumatic Diseases

    Hydroxychloroquine Retinopathy Still Alive and Well

    May 16, 2011

    How rheumatologists are affected by new guidelines from ophthalmology

    Ocular Disease Monitoring Critical to Avoid Retinal Toxicity from Hydroxychloroquine

    November 16, 2016

    Both due to its efficacy and favorable side effect profile when compared with alternative drugs for rheumatologic conditions, hydroxychloroquine is an important agent in rheumatologists’ armamentarium. However, one barrier to hydroxychloroquine use can be its effects on the eye (also see “Revised Retinopathy Screening Guidelines,”). Ocular side effects of hydroxychloroquine can include impact on the…

    APS: What Rheumatologists Should Know about Hughes Syndrome

    February 17, 2016

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences